Skip to content

A clinical study to evaluate the efficacy of the Sinhasyadi Avaleha in Doshika Kasa with special refference to cough in children of age group 3-12 years.

Randomised Open Controlled Clinical Study to evaluate the efficacy of Sinhasyadi Avaleha in Doshik Kasa with special refference to Cough in Children of age group 3 to12 years - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085869
Enrollment
90
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J418- Mixed simple and mucopurulent chronic bronchitis

Interventions

None listed

Sponsors

Yashwant Charitable Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 3year to 12year 2.Patient presenting with classical symptoms of Kasa as per their Dosha variety Vataj Pittaja Kaphaja since 2 weeks 3.Patient with low grade fever 4.Patient fit for adopted treatment 5.Patient will be selected irrespective of sex and socioeconomic status

Exclusion criteria

Exclusion criteria: 1.Patient presenting with symptoms of Tamaka Shwasa Kshayaja and Kshataj Kasa. 2.Patient presenting with complication like viral croup Laryngitis etc 3.Patient presenting with complication like Pneumonia COPD Emphysema TB Diptheria Pertusis etc 4. Patient associated with systemic illness presenting with cough 5.Patients with congenital anatomical abnormalities of chest and respiratory system

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy Of Sinhasyadi Avaleha in Doshika Kasa in children of age group 3 to 12 Years by assessing nature of cough frequency of bouts fever nasal discharge loss of appetite disturbance of sleep Timepoint: 8 weeks

Secondary

MeasureTime frame
1)Literature Study of Doshika Kasa 2) To study the probable mode of action of Sinhasyadi Avaleha 3)Standard procedure for preparation of Sinhasyadi Avaleha 4)Raw drug will be authentified & standardized 5)Clinical trial & data collection 6)Statistical analysis & conclusion 7)To observe adverse effect if anyTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDrGitanjali Radheshyam Pawar

Yashwant Ayurvedic College ,Kodoli

drpkdash25@gmail.com9423277590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026